Efficacy and safety of third-line or later-line targeted treatment for patients with metastatic colorectal cancer: a meta-analysis

Targeted therapy has been standardized in front-line therapies for metastatic colorectal cancer (mCRC), while explicit recommendations for third- or later-line are still lacking. This study evaluated the efficacy and safety of combining targeted therapy with chemotherapy in the third- or later-line...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Wen-Hui, Li, Xue-Wei, Ding, Ya-Qian, Wu, Na, Pei, Bei-Bei, Ma, Xiao-Yan, Xie, Jun, Yang, Wen-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265471/
https://www.ncbi.nlm.nih.gov/pubmed/37324019
http://dx.doi.org/10.3389/fonc.2023.1165040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265471/
https://www.ncbi.nlm.nih.gov/pubmed/37324019
http://dx.doi.org/10.3389/fonc.2023.1165040

Ejemplares similares